Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Cassie Jung is Chief Operating Officer at Aquestive Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Sep 8, 2025, each linked to the official Form 4.
Chief Operating Officer
Disclosures on record
2
Companies involved
1
As of the latest filing on , Cassie Jung reported holding 283,346 shares of Aquestive Therapeutics (AQST), worth about $1.11M at the last close of $4 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aquestive Therapeutics AQST | 283,346 | 283K direct | $4 | $1.11M | Sep 4, 2025 |
Is this Cassie Jung’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Aquestive TherapeuticsAQST
2 disclosures · Nov 2024 – Sep 2025 · 2 sold
Sep 4, 2025Sold~$311Kdisclosed Sep 8
DetailsOfficial recordNov 26, 2024Sold~$214disclosed Nov 27
DetailsOfficial recordOn the latest SEC Form 4, dated Sep 4, 2025, Cassie Jung reported holding 283,346 shares of Aquestive Therapeutics (AQST). At the last close of $4 on Nov 13, 2026, that is about $1.11M. This is the stake disclosed in filings, not a net worth.
Cassie Jung has no open-market purchase on record since 2024. Sales in 2 of the 3 years since 2024.
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2025.
Aquestive Therapeutics (AQST), from 2024 to 2025: 0 purchases and 2 sales.
Cassie Jung has no open-market purchase on record since 2024. Sales in 2 of the 3 years since 2024.
Cassie Jung reported 0 open-market purchases and 2 sales since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $311K1×1 trade |
| 2024 | — | $2141×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Cassie Jung reported 0 open-market purchases and 2 sales here, 2024 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
